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From 1996 to 2003, 16 outbreaks of enterotoxigenic
Escherichia coli (ETEC) infections in the United States and
on cruise ships were confirmed. E. coli serotype O169:H41
was identified in 10 outbreaks and was the only serotype in
6. This serotype was identified in 1 of 21 confirmed ETEC
outbreaks before 1996. 
E
nterotoxigenic Escherichia coli (ETEC) is an impor-
tant cause of diarrhea in the developing world and
among travelers and is increasingly recognized as a cause
of outbreaks in the United States (1). Dalton et al.
reviewed confirmed ETEC outbreaks that occurred both in
the United States and among passengers on cruise ships
that docked in U.S. ports from 1975 through 1995 (2).
Twenty-one such outbreaks caused by 17 different ETEC
serotypes occurred during this period; 7 (33%) occurred
among cruise ship passengers (2). Because laboratory tests
for the identification of ETEC are not widely available,
outbreaks caused by ETEC may escape recognition, and
healthcare workers may miss opportunities for treatment
and prevention. To improve recognition of ETEC out-
breaks, Dalton proposed that specimens from outbreaks of
gastroenteritis that meet certain criteria be referred for
ETEC testing at a public health reference laboratory. These
outbreaks include those for which routine stool cultures
have not yielded an etiologic agent and those which are
characterized by an incubation period of 24 to 48 hours, a
duration of illness >60 hours, and a diarrhea-to-vomiting
prevalence ratio of >2.5 (2).
The Study
For the 8-year period 1996 through 2003, we reviewed
all suspected ETEC outbreaks solely or jointly investigat-
ed by the Foodborne and Diarrheal Diseases Branch at the
Centers for Disease Control and Prevention (CDC). In
accordance with Dalton et al., we defined a confirmed
ETEC outbreak as one in which ETEC isolates of the
same serotype were isolated from >3 ill persons and no
other viral or bacterial pathogens were identified, or one
in which ETEC isolates of the same serotype were isolat-
ed from >10 ill persons and no more than one other bac-
terial or viral pathogen was identified in a single stool
specimen. Stool specimens collected during these investi-
gations were routinely cultured for Salmonella, Shigella,
Campylobacter,  E. coli O157:H7, Yersinia, and Vibrio
spp. In many instances, these specimens were also tested
for noroviruses.
To identify ETEC, patient specimens were plated to
MacConkey agar, and individual colonies or sweeps of
confluent growth were tested by polymerase chain reaction
(PCR) for heat-labile (LT) and heat-stable (ST) enterotox-
in genes (3). Using standard methods, we serotyped LT- or
ST-positive isolates for O and H antigens. ETEC isolates
were tested by the disk-diffusion method for susceptibility
to ampicillin, amoxicillin/clavulanic acid, ceftriaxone,
chloramphenicol, ciprofloxacin, gentamicin, kanamycin,
nalidixic acid, streptomycin, sulfisoxazole, tetracycline,
and trimethoprim-sulfamethoxazole (4). A PCR–restric-
tion fragment length polymorphism test was used to iden-
tify the H41 gene in selected nonmotile E. coli O169
isolates (5).
Conclusions
During the 8-year study period, CDC received isolates
from 59 outbreaks for ETEC testing. Sixteen met the crite-
ria for our definition of a confirmed ETEC outbreak; three
occurred on international cruise ships that docked in U.S.
ports and 12 occurred in the United States (Table). We
identified ETEC in specimens from six other outbreaks
that did not meet these criteria, either because ETEC iso-
lates of the same serotype were isolated from only two per-
sons (n = 2) or because we isolated additional bacterial
pathogens from the specimens (n = 4). 
The 16 ETEC outbreaks had a median of 41 ill persons
per outbreak (range 5–916), for a total of 2,865 patients.
From 81% to 100% of ill persons in each outbreak report-
ed diarrhea; less frequently reported symptoms included
abdominal cramps (66%–90%), fever (0%–73%), nausea
(44%–70%), and vomiting (0%–33%). In the 15 outbreaks
in which diarrhea and vomiting were reported, the median
“diarrhea-to-vomiting prevalence ratio” (the percentage of
patients who reported diarrhea divided by the percentage
of patients who reported vomiting) was 7.7 (range
2.9–undefined: the upper limit of the range is undefined
because in two outbreaks all ill persons interviewed denied
vomiting). In nine outbreaks with sufficient data, incuba-
tion periods among individual patients were 5–158 hours.
The median incubation period was 24–48 hours for 10 of
the 12 outbreaks for which it could be calculated. The
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USAduration of illness, reported in 11 outbreaks, was 0.3–21
days. The median duration of illness was >60 hours in 11
of the 13 outbreaks for which it could be calculated.
A vehicle was implicated in 11 (69%) outbreaks.
Unbottled ship’s water or beverages containing ice pre-
pared on board the ship were implicated in 2 of the 3 out-
breaks on cruise ships that had docked in foreign ports.
The source of the third international cruise ship outbreak
was not determined. Although no problems with chlorina-
tion of bunkered water were documented in the two out-
breaks, this problem has been seen in previous waterborne
ETEC outbreaks aboard cruise ships (6). Basil served on
board ship was implicated as the source of ETEC in the
remaining cruise ship outbreak (on a ship that docked only
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Table. Characteristics of enterotoxigenic Escherichia coli (ETEC) outbreaks,
a United States, 1996–2003 
No.  Mo/y  Location 
Setting 
(reference)  Presumed source  No. ill 
% 
Diarrhea 
(bloody) 
% 
Vomiting 
Median 
incubation, 
h (range) 
Median 
illness 
duration, 
days (range) 
No 
isolates 
Serotype/toxin 
type
b 
Antimicrobial 
resistance
c 
6  O169:H41/ST  Tc 
1  O6:H16/ LT,ST  Sensitive 
1  O27:H7/ST  St, Su, Tc 
1  3/96  Caribbean  Cruise ship  Drinking water  652  98 (9)  19  –  – 
1  O34:H10/ST  Tc 
8  O169:H41/ST  Tc 
3  O148:H28/ 
LT,ST 
Tc 
1  O78:H12/ST  Ch, St, Su, 
Tc, TmS 
2  4/97  Caribbean  Cruise ship 
(5) 
Drinking water, 
ice 
429  100 (6)  14  –  >3 
1  O27:H7/ST  St, Su, Tc 
3  4/97  California  Restaurant  Beans, 
enchilada, tacos, 
rice, tortilla chips 
41  95  17  24 (5–85)  2 (0.3–4)  11  O27:H7/ST  Sensitive 
4  6/97  Massachusetts  Boxed 
lunch 
Tomato, 
mozzarella salad 
33  97  33  48 (24–96)  3.7 (1–7)  5  O25:NM/ST  Sensitive 
5  7/97  Minnesota  Catered 
party 
Fresh vegetables  15  100  13  37 (8-158)  3.2 (0.4–6)  4  O169:H41/ST  Tc 
3  O6:H16/ LT,ST  Sensitive 
1  O6:H16/ LT,ST  St, Tc 
2  O169:H41/ST  Tc 
1  O148:H28/ 
LT,ST 
St, Su, Tc 
1  O148:H28/ 
LT,ST 
Tc 
6  4/98  Mexico-
Hawaii 
Cruise ship  –  397  96  33  –  – 
1  O27:H7/ST  St, Su, Tc 
7  6/98  Illinois  Catered 
parties 
Potato, 
macaroni, egg 
salads 
916  100  8  50 (40–76)  5 (2–9)  11  O6:H16/ LT,ST  Sensitive 
7  O6:H16/ LT,ST  Ap, St, Su, 
Tc 
1  O159:H4/LT  Ap, St, Su, 
Tc, TmS 
8  8/98  Minnesota  Restaurant 
(6) 
Parsley  66  100 (0)  6  25  8 
1  O27:H7/ST  St, Su, Tc 
9  9/98  Minnesota  Restaurant  –  5  100 (0)  0  48  6  3  O169:H41/ST  St, Su, Tc 
10  5/00  Washington  Cruise ship  Basil  100  100  5  40 (27–67)  10 (0.5–21)  3  O169:H41/ST  Tc 
11  6/00  New York  Banquet  –  40  97 (0)  3  48 (24–96)  3 (1–8)  5  O169:H41/ST  Tc 
12  7/00  Utah  Wedding 
rehearsal 
–  45  100  29  33 (18–59)  2.3 (1–3)  5  O27:H7/ST  St, Su, Tc 
13  7/01  Wisconsin  Catered 
party 
Quesadillas, 
fajitas, nacho 
chips, beans 
21  100  –  38 (9–70)  6 (1–8)  3  O169:H41/ST  Tc 
3  O169:H41/ST  Ap, Tc 
1  O169:H41/ST  Tc 
2  O6:H16/LT,ST  Sensitive 
14  8/01  Illinois  Catered 
party 
–  24  100  0  –  – 
1  O25:NM/ST  Ap 
15  10/02  Oregon  Catered 
party 
Garlic chicken 
lasagna 
40  98 (13)  15  72 (24–144)  5  3  O27:H7/ST  St, Su,Tc 
16  8/03  Tennessee  Catered 
party 
Catfish, coleslaw  41  81 (0)  5  2  2.5  12  0169:H49  Tc 
aAn outbreak is defined as $3 ill persons infected with the same ETEC serotype and no other viral or bacterial pathogens, or >10 ill persons with the same serotype and no 
more than one other bacterial or viral pathogen identified. 
  
bNM, nonmotile; LT, heat-labile toxin; ST, heat-stable toxin. 
cAp, ampicillin; Ch, chloramphenicol; St, streptomycin; Su, sulfisoxazole; Tc, tetracycline; TmS, trimethoprim-sulfamethoxazole. in U.S. ports). One other outbreak was attributed to a fresh
herb (parsley) served raw (7). Salads made with raw veg-
etables were implicated in four other domestic outbreaks.
If we define a strain as each ETEC serotype identified
during an outbreak that has a unique antimicrobial resist-
ance pattern, we identified a total of 30 strains represent-
ing eight different serotypes in specimens from the 16
outbreaks (Table). In five outbreaks, we isolated more than
one ETEC serotype. Heat-stable toxin (ST)-producing E.
coli O169:H41 was the most commonly identified
serotype. This serotype was identified as the only pathogen
in specimens from six outbreaks in the United States and
was identified along with other ETEC serotypes in four
additional outbreaks. Three of these four outbreaks
occurred on international cruise ships. In 21 previously
reported ETEC outbreaks, E. coli O169:H41 had been iso-
lated only once, from an outbreak that occurred among
international cruise ship passengers in 1995, in which
another ETEC serotype predominated (2). By all of the
basic epidemiologic and clinical characteristics that we
analyzed, outbreaks in which E. coli O169:H41 was iden-
tified alone, or in combination with other serotypes, did
not appear to differ from outbreaks in which this emerging
strain was not identified.
Resistance to antimicrobial agents remained common
among ETEC isolates (Table). Twenty-four (80%) of the
30 strains were resistant to tetracycline, 11 (38%) were
resistant to sulfisoxazole, 4 (13%) were resistant to ampi-
cillin, and 2 (7%) were resistant to trimethoprim-sul-
famethoxazole. All strains of O169:H41 were resistant to
tetracycline, and two were also resistant to at least one
additional antimicrobial drug. Only two outbreaks were
caused exclusively by pan-sensitive ETEC strains (7%).
A comparison of ETEC outbreaks reported to CDC
from 1996 through 2003 with those from previous years
shows that outbreaks on cruise ships and in the United
States continue to occur and that antimicrobial resistance
among ETEC isolates remains common. Raw vegetables
and herbs have been increasingly implicated as the vehi-
cles for ETEC outbreaks in recent years. This finding is in
keeping with an increase in produce-associated outbreaks
among other foodborne bacterial pathogens (8). Finally, a
new ETEC serotype, ST-producing O169:H41, has
become predominant.
The first report of O169:H41 was in association with a
foodborne outbreak in 1991 in Japan, where this serotype
continues to be isolated (9–11). Hamada reported four out-
breaks that occurred from June 1997 to August 1998; the
largest of these outbreaks had a 57% attack rate and result-
ed in approximately 2,800 cases. All four outbreaks
occurred at either restaurants or catered events (11).
Contaminated wakame seaweed was implicated in one of
the outbreaks and considered the likely cause in another
(11). Nishakawa et al. report that O169:H41 has become
the most prevalent ETEC serotype in Japan (12). 
In 1995, CDC detected this serotype for the first time
during an outbreak on a Caribbean cruise ship. It was iden-
tified during two additional Caribbean cruise ship out-
breaks before causing a domestic outbreak in Minnesota in
1997. In addition to being identified in 10 of the 16 ETEC
outbreaks that met our criteria, O169:H41 was also a pre-
dominant serotype in 4 of the 6 ETEC outbreaks that did
not meet our criteria for a confirmed outbreak, either
because the serotype was isolated from two persons only
or because an additional pathogen was also isolated in the
outbreak.
The emergence and eventual predominance of
O169:H41 in the United States and Japan may have impor-
tant implications for ETEC vaccine producers. Nishikawa
et al. characterized strains of O169:H41 from Japan and
reported that they are not clonal and that they possess a
novel colony-forming factor (12).
From 1996 through 1999, laboratory-confirmed ETEC
outbreaks represented 0.2% of all foodborne outbreaks
reported to CDC (13). This number is likely to be an under-
estimate because special diagnostic tests are required to
confirm ETEC. Seventy-one percent of outbreaks of food-
borne illness reported to CDC during this period were of
unknown cause. In a previous study, Hall et al. demonstrat-
ed that the epidemiologic and clinical syndrome in 1.1% of
outbreaks of unknown cause reported to CDC from 1982
through 1989 was compatible with infections caused by
ETEC or STEC (14). ETEC is also responsible for some
episodes of sporadic diarrheal disease. When researchers
systematically looked for it, they isolated ETEC from 1.4%
of stool samples from patients visiting urban and rural
health maintenance organization clinics in Minnesota for
diarrhea (15). Our data suggest that the clinical criteria pro-
posed by Dalton et al. for suspecting ETEC as a cause of an
outbreak of unknown cause (median incubation 24–48
hours, mean or median duration >60 hours, and diarrhea-to-
vomiting prevalence ratio >2.5) remain valid.
The epidemiology of ETEC outbreaks in the United
States is changing, but the incidence of these outbreaks
does not appear to be decreasing. Researchers cannot use
routine stool cultures to detect ETEC, and delays in stool
sample collection for >7 days greatly reduces yield
(16,17). For outbreaks that meet the clinical profile and for
which routine stool diagnostic tests have not yielded an
enteric pathogen, physicians and public health authorities
should send E. coli isolates to reference laboratories, such
as CDC, for ETEC testing.
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